Cardiovascular diseases rank as the top cause of death worldwide, affecting an estimated 442.7 million individuals and resulting in approximately 17.9 million deaths annually, which constitutes about 31% of all global mortality (
1,
2). Iran exhibits one of the highest age-standardized prevalence rates of cardiovascular diseases, with more than 9,000 cases per 100,000 individuals (
3).
Ischemic heart disease (IHD), also known as coronary artery disease and cardiovascular atherosclerotic disease, currently stands as one of the leading causes of death globally (
4). In 2019, within the Middle East and North Africa region (including Iran), IHD was the predominant cause of death, accounting for one-quarter of all deaths (799,484.4 deaths). That year, IHD was also recognized as the principal cause of both overall and premature mortality in Iran (
5,
6). While a significant reduction in IHD-related mortality has been observed in Western countries due to a focus on primary prevention and advancements in diagnosis and treatment, IHD continues to present new public health challenges in developing nations (
7).
Ischemic heart disease (IHD) typically presents clinically as ischemic cardiomyopathy or myocardial infarction. An increasing number of individuals with non-fatal IHD suffer from chronic disabilities and a reduced quality of life (QoL) (
6).
Revascularization, or reopening of coronary arteries, is a prevalent treatment for patients with IHD. This approach encompasses 2 primary methods: coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) (
8). PCI is the most frequently performed procedure for the revascularization of IHD, and significant progress in managing IHD with PCI has been achieved over recent decades (
9). The core techniques of PCI include balloon angioplasty and coronary stenting, making it considered less invasive compared to CABG (
10). Patients with IHD who undergo PCI often can resume partial normal activities with a low risk of cardiac events (
11). However, the probability of requiring repeat angiography and further revascularization is higher in PCI patients than in those who undergo CABG (
12).
Numerous studies have underscored the importance of assessing QoL as a crucial outcome measure in the treatment of IHD (
13). There is evidence from several studies indicating that treatment for IHD can enhance patients' QoL. For instance, a systematic review and meta-analysis by Kaambwa et al. found that QoL in patients with acute coronary syndrome improves following various treatments, including PCI (
14). Nevertheless, research has shown that the QoL for these patients tends to decline over time (
15). In a study of Austrian patients with cardiovascular disease who underwent interventions such as PCI, Höfer et al. observed a significant reduction in their QoL two years after completing a cardiac rehabilitation program (
16). Similarly, Bahramnezhad et al. reported a decrease in QoL among patients who had undergone balloon angioplasty three months after the procedure (
17).
Healthcare professionals, including nurses, are encouraged to implement interventions for post-PCI patients to maintain and improve their QoL (
15). Encouraging patients post-PCI to adopt healthy behaviors and self-care practices has been shown to effectively minimize complications and thereby improve their QoL. The information-motivation-behavioral (IMB) model, originally developed by Fisher in 1992 to address AIDS-related risk behaviors, aims to facilitate behavior change by focusing on three essential elements: information, motivation, and behavioral skills (
18).
Previous research has shown that interventions based on the Information-Motivation-Behavioral (IMB) model have improved the QoL of patients with type 2 diabetes (
19) and enhanced the adherence of patients with chronic obstructive pulmonary disease (COPD) to their inhaler regimens (
20). In Iran, 2 studies have demonstrated the efficacy of the IMB model in improving body size in women who have undergone bariatric surgery and in promoting adherence among CABG patients (
21,
22). The IMB model suggests that motivation comprises 2 aspects: Belief in the personal benefits of behavioral changes (positive insight) and the perception of social support for engaging in targeted behaviors (social motivation) (
23). According to this model, it is crucial to identify and address knowledge, motivation, and behavioral skills gaps in post-PCI patients to enhance their QoL.
The literature review indicates that there has not yet been a study investigating the impact of this model on the QoL of post-PCI patients.